AU4739600A - Method for subtracting cdnas by suppressing the synthesis of specifically targeted mrnas - Google Patents

Method for subtracting cdnas by suppressing the synthesis of specifically targeted mrnas

Info

Publication number
AU4739600A
AU4739600A AU47396/00A AU4739600A AU4739600A AU 4739600 A AU4739600 A AU 4739600A AU 47396/00 A AU47396/00 A AU 47396/00A AU 4739600 A AU4739600 A AU 4739600A AU 4739600 A AU4739600 A AU 4739600A
Authority
AU
Australia
Prior art keywords
suppressing
synthesis
specifically targeted
targeted mrnas
cdnas
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU47396/00A
Inventor
Jerry Pelletier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McGill University
Original Assignee
McGill University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McGill University filed Critical McGill University
Publication of AU4739600A publication Critical patent/AU4739600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
AU47396/00A 1999-05-17 2000-05-17 Method for subtracting cdnas by suppressing the synthesis of specifically targeted mrnas Abandoned AU4739600A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13454899P 1999-05-17 1999-05-17
US60134548 1999-05-17
PCT/CA2000/000586 WO2000070039A1 (en) 1999-05-17 2000-05-17 METHOD FOR SUBTRACTING cDNAs BY SUPPRESSING THE SYNTHESIS OF SPECIFICALLY TARGETED mRNAs

Publications (1)

Publication Number Publication Date
AU4739600A true AU4739600A (en) 2000-12-05

Family

ID=22463856

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47396/00A Abandoned AU4739600A (en) 1999-05-17 2000-05-17 Method for subtracting cdnas by suppressing the synthesis of specifically targeted mrnas

Country Status (2)

Country Link
AU (1) AU4739600A (en)
WO (1) WO2000070039A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3578697B1 (en) 2012-01-26 2024-03-06 Tecan Genomics, Inc. Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
JP6181751B2 (en) 2012-06-18 2017-08-16 ニューゲン テクノロジーズ， インコーポレイテッド Compositions and methods for negative selection of unwanted nucleic acid sequences
US20150011396A1 (en) 2012-07-09 2015-01-08 Benjamin G. Schroeder Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing
EP2971130A4 (en) 2013-03-15 2016-10-05 Nugen Technologies Inc Sequential sequencing
US9546399B2 (en) 2013-11-13 2017-01-17 Nugen Technologies, Inc. Compositions and methods for identification of a duplicate sequencing read
EP3090060B1 (en) * 2013-12-30 2019-02-20 CureVac AG Methods for rna analysis
AU2014375404C1 (en) * 2013-12-30 2020-11-19 CureVac Manufacturing GmbH Methods for RNA analysis
US9745614B2 (en) 2014-02-28 2017-08-29 Nugen Technologies, Inc. Reduced representation bisulfite sequencing with diversity adaptors
SG10201808063PA (en) * 2014-03-19 2018-10-30 Ionis Pharmaceuticals Inc Compositions for modulating ataxin 2 expression
EP3177740B1 (en) 2014-08-06 2021-01-13 Nugen Technologies, Inc. Digital measurements from targeted sequencing
US20190017100A1 (en) * 2015-07-01 2019-01-17 Curevac Ag Method for analysis of an rna molecule
US11624064B2 (en) 2016-06-13 2023-04-11 Grail, Llc Enrichment of mutated cell free nucleic acids for cancer detection
US11099202B2 (en) 2017-10-20 2021-08-24 Tecan Genomics, Inc. Reagent delivery system
TW202020154A (en) 2018-07-25 2020-06-01 美商Ionis製藥公司 Compounds and methods for reducing atxn2 expression
US11680261B2 (en) 2018-11-15 2023-06-20 Grail, Inc. Needle-based devices and methods for in vivo diagnostics of disease conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3855864T2 (en) * 1987-11-30 1997-09-25 Univ Iowa Res Found DNA MOLECULES STABILIZED BY MODIFICATIONS ON THE 3'-TERMINAL PHOSPHODIESTERBINDING, THEIR USE AS NUCLEIC ACID PROBE AND AS A THERAPEUTIC AGENT FOR INHIBITING THE EXPRESSION OF SPECIFIC TARGET GENES
CA2005252C (en) * 1988-12-13 2001-07-17 Nahum Sonenberg Isolation of full-length cdna clones and capped mrna
CA2141430C (en) * 1992-08-04 2009-05-12 Sherrol H. Mcdonough Nucleic acid sequence amplification
US5891637A (en) * 1996-10-15 1999-04-06 Genentech, Inc. Construction of full length cDNA libraries

Also Published As

Publication number Publication date
WO2000070039A1 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
HUP0303803A3 (en) Enzymatic method for the enantioselective reduction of keto compounds
AU4739600A (en) Method for subtracting cdnas by suppressing the synthesis of specifically targeted mrnas
AU5005700A (en) Method for the manufacture of toothpaste
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
AU6432800A (en) Process for the synthesis of citalopram
AU7972200A (en) Process for the preparation of urea
AU2466700A (en) Process for the preparation of urea
AU7363000A (en) Method for reducing the risk of cancer
AU2376001A (en) Method for the manufacture of olefins
EP1556400A4 (en) Method for the preparation of 2-halo-2 -deoxyadenosine compounds from 2 -deoxyguanosine
AU2003256102A1 (en) Method for the selective preparation of 3-oxo-4-aza-5a-androstane compound
AU5976000A (en) Process for the manufacture of moldings
AU2003245880A1 (en) Process for the preparation of thioalkylamine derivatives
AU2002367890A1 (en) Process for the preparation of 4-methyl-thiazole-5-carbaldehyde intermediate
HUP0202530A2 (en) Method for the production of phosphonomethylglycin
AU2003225426A1 (en) Process for the preparation of urea
AU6830400A (en) Method for carrying out the targeted depolymerization of polysaccharides
AU2003294844A1 (en) Process for the preparation of catalyst microspheres
AU6275900A (en) Process for the cis-selective catalytic hydrogenation of cyclohexylidenamines
AU2002359034A1 (en) Process for the preparation of simvastatin
AU3299900A (en) Method for the production of aliphatic fluoroformates
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
AU3161701A (en) Method for producing nitroguanidine
AU2003275887A1 (en) Catalytic method for the production of carbonyl compounds
AU6028900A (en) Method for the preparation of urea

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase